Hypertrophy, Left Ventricular - 17 Studies Found
| Enrolling by invitation |
: Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure : Hypertrophy, Left Ventricular : 2015-10-30 :
|
| Completed |
: New-onset Diabetes and Left Ventricular Hypertrophy in Renal Transplantation :
|
| Recruiting |
: Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy : Hypertensive Left Ventricular Hypertrophy : 2013-04-30 :
|
| Completed |
: Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy :
|
| Completed |
: Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study :
: 2013-09-18 :
|
| Completed |
: Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction? :
: 2008-05-29 :
|
| Active, not recruiting |
: Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension? :
: 2014-08-18 :
|
| Terminated |
: The Effect of Heart Rate on Cardiac Index in Patients With Left Ventricular Hypertrophy :
: Device: Pacemaker Routine postoperative temporary pacemaker Rate change of 65-80-95-110-125 beats/second |
| Completed |
: Effects Of Volume Control Guided by Body Composition Monitor (BCM) on Blood Pressure and Cardiac Condition in Hemodialysis Patients : Left Ventricular Hypertrophy : 2009-09-09 :
|
| Completed |
: Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension :
|